Extension Study to Gather Data on Effect of Macugen on the Corneal Endothelium

NCT01573572 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

131

Enrollment

INDUSTRY

Sponsor class

Conditions

Age-Related Macular Degeneration
Retinal Vein Occlusion
Diabetic Macular Edema

Interventions

DRUG: pegaptanib sodium injection

Sponsor

Bausch & Lomb Incorporated